Global Human Cytomegalovirus Envelope Glycoprotein B Market Research Report 2025(Status and Outlook)
Report Overview
Human Cytomegalovirus (HCMV) Envelope Glycoprotein B (gB) is a critical viral surface protein essential for host cell entry, mediating fusion between the viral envelope and host cell membranes. It is a major target for neutralizing antibodies and a key antigen in vaccine development, given its role in viral infectivity and immune response modulation. The market for HCMV gB is primarily driven by its applications in diagnostics, therapeutics, and vaccine research, particularly in addressing congenital CMV infections and immunocompromised patients. Growing awareness of HCMV-related complications, coupled with advancements in recombinant protein technologies and immunogenicity studies, is fueling demand. However, challenges such as complex protein expression, regulatory hurdles, and high R&D costs may hinder market growth. Key players include biopharmaceutical companies and research institutions focusing on antiviral therapies and prophylactic vaccines. The market is expected to expand with increased funding for infectious disease research and the rising prevalence of HCMV infections globally.
This report provides a deep insight into the global Human Cytomegalovirus Envelope Glycoprotein B market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Cytomegalovirus Envelope Glycoprotein B Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Cytomegalovirus Envelope Glycoprotein B market in any manner.
Global Human Cytomegalovirus Envelope Glycoprotein B Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astellas Pharma Inc.
Trellis Bioscience
Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
Market Segmentation (by Type)
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Market Segmentation (by Application)
Infectious Disease
Oncology
Women's Health
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Cytomegalovirus Envelope Glycoprotein B Market
Overview of the regional outlook of the Human Cytomegalovirus Envelope Glycoprotein B Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Cytomegalovirus Envelope Glycoprotein B Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Cytomegalovirus Envelope Glycoprotein B, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Human Cytomegalovirus (HCMV) Envelope Glycoprotein B (gB) is a critical viral surface protein essential for host cell entry, mediating fusion between the viral envelope and host cell membranes. It is a major target for neutralizing antibodies and a key antigen in vaccine development, given its role in viral infectivity and immune response modulation. The market for HCMV gB is primarily driven by its applications in diagnostics, therapeutics, and vaccine research, particularly in addressing congenital CMV infections and immunocompromised patients. Growing awareness of HCMV-related complications, coupled with advancements in recombinant protein technologies and immunogenicity studies, is fueling demand. However, challenges such as complex protein expression, regulatory hurdles, and high R&D costs may hinder market growth. Key players include biopharmaceutical companies and research institutions focusing on antiviral therapies and prophylactic vaccines. The market is expected to expand with increased funding for infectious disease research and the rising prevalence of HCMV infections globally.
This report provides a deep insight into the global Human Cytomegalovirus Envelope Glycoprotein B market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Cytomegalovirus Envelope Glycoprotein B Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Cytomegalovirus Envelope Glycoprotein B market in any manner.
Global Human Cytomegalovirus Envelope Glycoprotein B Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astellas Pharma Inc.
Trellis Bioscience
Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
Market Segmentation (by Type)
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Market Segmentation (by Application)
Infectious Disease
Oncology
Women's Health
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Cytomegalovirus Envelope Glycoprotein B Market
Overview of the regional outlook of the Human Cytomegalovirus Envelope Glycoprotein B Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Cytomegalovirus Envelope Glycoprotein B Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Cytomegalovirus Envelope Glycoprotein B, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Key Market Segments
1.2.1 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
1.2.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Product Life Cycle
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (2020-2025)
3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Cytomegalovirus Envelope Glycoprotein B Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Situation and Trends
3.8.1 Human Cytomegalovirus Envelope Glycoprotein B Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B INDUSTRY CHAIN ANALYSIS
4.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Cytomegalovirus Envelope Glycoprotein B Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Cytomegalovirus Envelope Glycoprotein B Market
5.7 ESG Ratings of Leading Companies
6 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2025)
6.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Type (2020-2025)
6.4 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2020-2025)
7 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Sales by Application (2020-2025)
7.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) by Application (2020-2025)
7.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Application (2020-2025)
8 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET SALES BY REGION
8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region
8.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region
8.3 North America
8.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
8.3.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
8.4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.5.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
8.6.2 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.7.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET PRODUCTION BY REGION
9.1 Global Production of Human Cytomegalovirus Envelope Glycoprotein B by Region(2020-2025)
9.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2025)
9.3 Global Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Cytomegalovirus Envelope Glycoprotein B Production
9.4.1 North America Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.4.2 North America Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Production
9.5.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Cytomegalovirus Envelope Glycoprotein B Production (2020-2025)
9.6.1 Japan Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.6.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Cytomegalovirus Envelope Glycoprotein B Production (2020-2025)
9.7.1 China Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.7.2 China Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Astellas Pharma Inc.
10.1.1 Astellas Pharma Inc. Basic Information
10.1.2 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.1.4 Astellas Pharma Inc. Business Overview
10.1.5 Astellas Pharma Inc. SWOT Analysis
10.1.6 Astellas Pharma Inc. Recent Developments
10.2 Trellis Bioscience
10.2.1 Trellis Bioscience Basic Information
10.2.2 Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.2.3 Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.2.4 Trellis Bioscience Business Overview
10.2.5 Trellis Bioscience SWOT Analysis
10.2.6 Trellis Bioscience Recent Developments
10.3 Inc.
10.3.1 Inc. Basic Information
10.3.2 Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.3.3 Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.3.4 Inc. Business Overview
10.3.5 Inc. SWOT Analysis
10.3.6 Inc. Recent Developments
10.4 Vakzine Projekt Management GmbH
10.4.1 Vakzine Projekt Management GmbH Basic Information
10.4.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.4.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.4.4 Vakzine Projekt Management GmbH Business Overview
10.4.5 Vakzine Projekt Management GmbH Recent Developments
10.5 VBI Vaccine Inc
10.5.1 VBI Vaccine Inc Basic Information
10.5.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.5.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.5.4 VBI Vaccine Inc Business Overview
10.5.5 VBI Vaccine Inc Recent Developments
10.6 Vical Incorporated
10.6.1 Vical Incorporated Basic Information
10.6.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.6.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.6.4 Vical Incorporated Business Overview
10.6.5 Vical Incorporated Recent Developments
11 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET FORECAST BY REGION
11.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast
11.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country
11.2.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region
11.2.4 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Cytomegalovirus Envelope Glycoprotein B by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Human Cytomegalovirus Envelope Glycoprotein B by Type (2026-2033)
12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Human Cytomegalovirus Envelope Glycoprotein B by Type (2026-2033)
12.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Application (2026-2033)
12.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) Forecast by Application
12.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Key Market Segments
1.2.1 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
1.2.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Product Life Cycle
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (2020-2025)
3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Cytomegalovirus Envelope Glycoprotein B Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Situation and Trends
3.8.1 Human Cytomegalovirus Envelope Glycoprotein B Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B INDUSTRY CHAIN ANALYSIS
4.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Cytomegalovirus Envelope Glycoprotein B Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Cytomegalovirus Envelope Glycoprotein B Market
5.7 ESG Ratings of Leading Companies
6 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2025)
6.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Type (2020-2025)
6.4 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2020-2025)
7 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Sales by Application (2020-2025)
7.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) by Application (2020-2025)
7.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Application (2020-2025)
8 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET SALES BY REGION
8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region
8.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region
8.3 North America
8.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
8.3.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
8.4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.5.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
8.6.2 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
8.7.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET PRODUCTION BY REGION
9.1 Global Production of Human Cytomegalovirus Envelope Glycoprotein B by Region(2020-2025)
9.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2025)
9.3 Global Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Cytomegalovirus Envelope Glycoprotein B Production
9.4.1 North America Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.4.2 North America Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Production
9.5.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Cytomegalovirus Envelope Glycoprotein B Production (2020-2025)
9.6.1 Japan Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.6.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Cytomegalovirus Envelope Glycoprotein B Production (2020-2025)
9.7.1 China Human Cytomegalovirus Envelope Glycoprotein B Production Growth Rate (2020-2025)
9.7.2 China Human Cytomegalovirus Envelope Glycoprotein B Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Astellas Pharma Inc.
10.1.1 Astellas Pharma Inc. Basic Information
10.1.2 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.1.4 Astellas Pharma Inc. Business Overview
10.1.5 Astellas Pharma Inc. SWOT Analysis
10.1.6 Astellas Pharma Inc. Recent Developments
10.2 Trellis Bioscience
10.2.1 Trellis Bioscience Basic Information
10.2.2 Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.2.3 Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.2.4 Trellis Bioscience Business Overview
10.2.5 Trellis Bioscience SWOT Analysis
10.2.6 Trellis Bioscience Recent Developments
10.3 Inc.
10.3.1 Inc. Basic Information
10.3.2 Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.3.3 Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.3.4 Inc. Business Overview
10.3.5 Inc. SWOT Analysis
10.3.6 Inc. Recent Developments
10.4 Vakzine Projekt Management GmbH
10.4.1 Vakzine Projekt Management GmbH Basic Information
10.4.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.4.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.4.4 Vakzine Projekt Management GmbH Business Overview
10.4.5 Vakzine Projekt Management GmbH Recent Developments
10.5 VBI Vaccine Inc
10.5.1 VBI Vaccine Inc Basic Information
10.5.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.5.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.5.4 VBI Vaccine Inc Business Overview
10.5.5 VBI Vaccine Inc Recent Developments
10.6 Vical Incorporated
10.6.1 Vical Incorporated Basic Information
10.6.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Overview
10.6.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Market Performance
10.6.4 Vical Incorporated Business Overview
10.6.5 Vical Incorporated Recent Developments
11 HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B MARKET FORECAST BY REGION
11.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast
11.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country
11.2.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region
11.2.4 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Cytomegalovirus Envelope Glycoprotein B by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Human Cytomegalovirus Envelope Glycoprotein B by Type (2026-2033)
12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Human Cytomegalovirus Envelope Glycoprotein B by Type (2026-2033)
12.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Application (2026-2033)
12.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) Forecast by Application
12.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Cytomegalovirus Envelope Glycoprotein B Market Size Comparison by Region (M USD)
Table 5. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2024)
Table 10. Global Market Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (K MT)
Table 26. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type (M USD)
Table 27. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) by Type (2020-2025)
Table 28. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2025)
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) by Type (2020-2025)
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Share by Type (2020-2025)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/KG) by Type (2020-2025)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) by Application
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K MT)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application (2020-2025) & (M USD)
Table 37. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application (2020-2025)
Table 38. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Application (2020-2025)
Table 39. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K MT)
Table 40. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2025)
Table 41. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (2020-2025) & (M USD)
Table 42. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region (2020-2025)
Table 43. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K MT)
Table 44. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K MT)
Table 46. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (2020-2025) & (M USD)
Table 49. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K MT)
Table 50. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (2020-2025) & (M USD)
Table 53. Global Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) by Region(2020-2025)
Table 54. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2025)
Table 56. Global Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Astellas Pharma Inc. Basic Information
Table 62. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 63. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Astellas Pharma Inc. Business Overview
Table 65. Astellas Pharma Inc. SWOT Analysis
Table 66. Astellas Pharma Inc. Recent Developments
Table 67. Trellis Bioscience Basic Information
Table 68. Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 69. Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Trellis Bioscience Business Overview
Table 71. Trellis Bioscience SWOT Analysis
Table 72. Trellis Bioscience Recent Developments
Table 73. Inc. Basic Information
Table 74. Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 75. Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Inc. Business Overview
Table 77. Inc. SWOT Analysis
Table 78. Inc. Recent Developments
Table 79. Vakzine Projekt Management GmbH Basic Information
Table 80. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 81. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Vakzine Projekt Management GmbH Business Overview
Table 83. Vakzine Projekt Management GmbH Recent Developments
Table 84. VBI Vaccine Inc Basic Information
Table 85. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 86. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. VBI Vaccine Inc Business Overview
Table 88. VBI Vaccine Inc Recent Developments
Table 89. Vical Incorporated Basic Information
Table 90. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 91. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Vical Incorporated Business Overview
Table 93. Vical Incorporated Recent Developments
Table 94. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Cytomegalovirus Envelope Glycoprotein B Market Size Comparison by Region (M USD)
Table 5. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2024)
Table 10. Global Market Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (K MT)
Table 26. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type (M USD)
Table 27. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) by Type (2020-2025)
Table 28. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2025)
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) by Type (2020-2025)
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Share by Type (2020-2025)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/KG) by Type (2020-2025)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) by Application
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025) & (K MT)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application (2020-2025) & (M USD)
Table 37. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application (2020-2025)
Table 38. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Application (2020-2025)
Table 39. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K MT)
Table 40. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2025)
Table 41. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (2020-2025) & (M USD)
Table 42. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region (2020-2025)
Table 43. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K MT)
Table 44. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K MT)
Table 46. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (2020-2025) & (M USD)
Table 49. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K MT)
Table 50. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (2020-2025) & (M USD)
Table 53. Global Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) by Region(2020-2025)
Table 54. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2025)
Table 56. Global Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Human Cytomegalovirus Envelope Glycoprotein B Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Astellas Pharma Inc. Basic Information
Table 62. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 63. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Astellas Pharma Inc. Business Overview
Table 65. Astellas Pharma Inc. SWOT Analysis
Table 66. Astellas Pharma Inc. Recent Developments
Table 67. Trellis Bioscience Basic Information
Table 68. Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 69. Trellis Bioscience Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Trellis Bioscience Business Overview
Table 71. Trellis Bioscience SWOT Analysis
Table 72. Trellis Bioscience Recent Developments
Table 73. Inc. Basic Information
Table 74. Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 75. Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Inc. Business Overview
Table 77. Inc. SWOT Analysis
Table 78. Inc. Recent Developments
Table 79. Vakzine Projekt Management GmbH Basic Information
Table 80. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 81. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Vakzine Projekt Management GmbH Business Overview
Table 83. Vakzine Projekt Management GmbH Recent Developments
Table 84. VBI Vaccine Inc Basic Information
Table 85. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 86. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. VBI Vaccine Inc Business Overview
Table 88. VBI Vaccine Inc Recent Developments
Table 89. Vical Incorporated Basic Information
Table 90. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Overview
Table 91. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Vical Incorporated Business Overview
Table 93. Vical Incorporated Recent Developments
Table 94. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD), 2024-2033
Figure 5. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) (2020-2033)
Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Cytomegalovirus Envelope Glycoprotein B Product Life Cycle
Figure 13. Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturers in 2024
Figure 14. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers in 2024
Figure 15. Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2024
Figure 18. Industry Chain Map of Human Cytomegalovirus Envelope Glycoprotein B
Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Market PEST Analysis
Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type
Figure 27. Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2020-2025)
Figure 28. Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type in 2024
Figure 29. Market Size Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2020-2025)
Figure 30. Market Size Share of Human Cytomegalovirus Envelope Glycoprotein B by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application
Figure 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2024
Figure 35. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application (2020-2025)
Figure 36. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2024
Figure 37. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2025)
Figure 39. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region (2020-2025)
Figure 40. North America Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2024
Figure 43. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Country in 2024
Figure 45. U.S. Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Cytomegalovirus Envelope Glycoprotein B Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2024
Figure 53. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Country in 2024
Figure 55. Germany Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region in 2024
Figure 68. China Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (K MT)
Figure 79. South America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2024
Figure 80. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (M USD)
Figure 81. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Country in 2024
Figure 82. Brazil Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Cytomegalovirus Envelope Glycoprotein B Production Market Share by Region (2020-2025)
Figure 103. North America Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Type (2026-2033)
Figure 111. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2026-2033)
Figure 112. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD), 2024-2033
Figure 5. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) (2020-2033)
Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Cytomegalovirus Envelope Glycoprotein B Product Life Cycle
Figure 13. Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturers in 2024
Figure 14. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers in 2024
Figure 15. Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2024
Figure 18. Industry Chain Map of Human Cytomegalovirus Envelope Glycoprotein B
Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Market PEST Analysis
Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type
Figure 27. Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2020-2025)
Figure 28. Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type in 2024
Figure 29. Market Size Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2020-2025)
Figure 30. Market Size Share of Human Cytomegalovirus Envelope Glycoprotein B by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application
Figure 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
Figure 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application in 2024
Figure 35. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application (2020-2025)
Figure 36. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2024
Figure 37. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2025)
Figure 39. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region (2020-2025)
Figure 40. North America Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2024
Figure 43. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Country in 2024
Figure 45. U.S. Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Cytomegalovirus Envelope Glycoprotein B Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Cytomegalovirus Envelope Glycoprotein B Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2024
Figure 53. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Country in 2024
Figure 55. Germany Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region in 2024
Figure 68. China Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (K MT)
Figure 79. South America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2024
Figure 80. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (M USD)
Figure 81. South America Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Country in 2024
Figure 82. Brazil Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Cytomegalovirus Envelope Glycoprotein B Production Market Share by Region (2020-2025)
Figure 103. North America Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Cytomegalovirus Envelope Glycoprotein B Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Type (2026-2033)
Figure 111. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2026-2033)
Figure 112. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share Forecast by Application (2026-2033)
